Dr. Marta Lustig Successfully Completes PhD

We are pleased to announce the successful completion of Dr. Marta Lustig’s PhD within the Clinical Research Unit, CATCH ALL. Her thesis, “Sialic acid/Siglec axis regulates antibody-mediated neutrophil cytotoxicity towards cancer cells,” has contributed valuable insights to the field of cancer immunology. Dr. Lustig’s research, guided by her examiners, Prof. Thomas Valerius and Prof. Axel Scheidig, advances our understanding of the immune system’s role in targeting cancer cells. This work has been part of our project 6 “CD47 blockade”.  We congratulate Marta on this significant academic milestone and look forward to her continued contributions to CATCH ALL.

Additional Details

Contacts:

Dr. rer. nat. Marta Lustig

Doctoral Researcher
Division of Stem Cell Transplantation and Immunotherapy / University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Marta.Lustig[at]uksh.de
P6

Prof. Dr. med. Thomas Valerius 

Principle Investigator
Division of Stem Cell Transplantation and Immunotherapy / University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
t.valerius@med2.uni-kiel.de
P6

Participating Institutes